Welcome to our dedicated page for Cognyte Software SEC filings (Ticker: CGNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cognyte Software Ltd. (NASDAQ: CGNT) SEC filings page brings together the company’s regulatory disclosures as a foreign private issuer. Cognyte files an annual report on Form 20-F and furnishes current reports on Form 6-K under the Securities Exchange Act of 1934. These filings include press releases on quarterly financial results, conference call announcements, share repurchase authorizations and materials related to the annual general meeting of shareholders.
Recent 6-K filings reference press releases such as “Cognyte Reports Second Quarter Fiscal 2026 Financial Results,” “Cognyte to Announce Second Quarter FYE26 Financial Results,” and “Cognyte to Announce Third Quarter FYE26 Financial Results.” Other 6-Ks furnish the notice and proxy statement for the annual general meeting, detailed voting results on director elections, compensation policies and auditor appointments, and information about a share repurchase program.
Through this page, users can review Cognyte’s GAAP financial statements, non-GAAP metrics and key performance indicators as incorporated by reference from its press releases into registration statements on Form S-8. The filings also document governance decisions, including compensation policies for executive officers and directors and the appointment of independent auditors.
Stock Titan enhances access to these CGNT filings with AI-powered tools that summarize lengthy documents and highlight important sections, helping users understand the implications of financial results, corporate actions and governance proposals more quickly. Investors and researchers can use this resource to track Cognyte’s reporting history, monitor ongoing disclosure practices and analyze how the company communicates financial performance and corporate decisions over time.
CGNT reported a Form 144 notice proposing the sale of ordinary shares issued under restricted stock unit awards. The filing lists multiple RSU grant dates and share quantities, including 12,000 shares (04/23/2021) and 13,863 shares (02/01/2021). Broker information shows Oppenheimer & Co. Inc. and the entry lists 04/06/2026 and NASDAQ.
Cognyte Software Ltd. files its annual report on Form 20-F for the year ended January 31, 2026, describing its business as a software-driven provider of investigative analytics solutions to government agencies worldwide.
The company highlights that a substantial majority of revenue comes from national, regional and local government customers, with one government customer representing approximately 18% of total revenue in fiscal 2026 and two government customers jointly representing about 30% and 28% of revenue in fiscal 2025 and 2024.
The report devotes extensive discussion to risks from macroeconomic pressures, budget constraints and shutdowns affecting government IT spending, global supply chain disruptions, inflation and foreign exchange volatility, new tariffs and trade restrictions, evolving regulations, and geopolitical instability. Cognyte also emphasizes risks tied to its Israeli base amid regional conflicts, rapid technological change including AI and generative AI integration, reputational scrutiny over potential misuse of its solutions, complex government procurement processes, long sales cycles, export-control limits, regulatory and self-imposed customer restrictions, and intense competition for both government contracts and skilled technical personnel.
Cognyte Software Ltd. reported a strong fourth quarter and a turnaround fiscal 2026. Q4 revenue reached $106.2 million, up 12.4%, with GAAP operating income of $5.2 million and adjusted EBITDA of $15.0 million, up 62.5% as margins improved.
For the year ended January 31, 2026, revenue was $400.0 million, up 14.1%. GAAP operating income was $13.3 million versus a prior-year loss, and adjusted EBITDA rose to $48.2 million, a 66% increase. GAAP net income was $4.6 million, while net loss attributable to Cognyte narrowed to $0.6 million.
The company ended the year with $116.9 million in cash and no debt, supported by $40.3 million in operating cash flow. It repurchased about 592,000 shares for $5.5 million in Q4 and has bought $26.7 million of stock since program inception. For fiscal 2027, Cognyte guides to revenue of about $448 million, adjusted EBITDA of roughly $68 million, and non-GAAP diluted EPS of $0.47, implying continued double-digit growth and margin expansion.
Cognyte Software Ltd. Chief Customer Officer Sharon Chouli filed an initial ownership report showing beneficial ownership of 677,386 Ordinary Shares. This establishes her baseline equity stake as a senior executive.
The total includes performance share units and restricted share units granted in 2023, 2024, 2025 and 2026, with vesting dates running from April 2026 through March 2028.
Cognyte Software Ltd. Chief Product Officer Cohen Gil filed an initial Form 3 reporting beneficial ownership of 612,445 Ordinary Shares. This total includes several blocks of restricted share units (RSUs) and performance share units (PSUs) that will convert into Ordinary Shares as they vest.
The holdings include 12,500 RSU-based shares granted on July 26, 2023 that vest on May 10, 2026, and 38,310 RSU-based shares granted on March 26, 2024 with vesting dates in 2026 and 2027. They also include 59,525 RSU-based shares granted on March 24, 2025 vesting over five dates through March 24, 2028, 142,786 PSU-based shares granted on March 26, 2024 vesting on April 11, 2026, and 69,914 RSU-based shares granted on March 16, 2026 vesting in six equal semi-annual installments over three years.
Cognyte Software Ltd.’s Chief Revenue Officer, Nuri Efraim, has filed an initial Form 3 reporting beneficial ownership of 611,676 Ordinary Shares. This position includes a mix of currently held shares and equity awards such as restricted share units (RSUs) and performance share units (PSUs).
The filing notes RSU and PSU grants made between July 2023 and March 2026, with vesting schedules extending into 2028. These awards convert into Ordinary Shares over time as vesting and performance conditions are met, tying a substantial portion of the CRO’s compensation directly to Cognyte’s future performance.
Cognyte Software Ltd.’s Chief Financial Officer David Abadi filed a Form 3 showing beneficial ownership of 1,026,792 Ordinary Shares, held directly. This total includes performance share units and restricted share units that will settle into Ordinary Shares as they vest between 2026 and 2028.
The holdings comprise 172,532 Ordinary Shares represented by PSUs granted on March 26, 2024, which will vest on April 11, 2026, and multiple blocks of RSUs: 18,334 shares vesting May 10, 2026, 46,291 shares vesting in three tranches from March 2026 to March 2027, 76,885 shares vesting in five tranches from March 2026 to March 2028, and 90,305 shares vesting in six semi-annual installments over three years from March 16, 2026.
Cognyte Software Ltd. director Nurit Benjamini filed an initial ownership report showing holdings tied to 40,022 Ordinary Shares. These are entirely represented by restricted share units granted on March 31, 2025 and March 16, 2026, with vesting scheduled through March 24, 2027.
Cognyte Software Ltd. director Matthew K. O'Neill filed an initial ownership report showing beneficial ownership of 40,022 Ordinary Shares. This includes 19,048 shares represented by restricted share units (RSUs) granted on March 24, 2025 that vest on March 24, 2026, and 20,974 shares represented by RSUs granted on March 16, 2026 that vest in four equal quarterly installments over one year. The filing records current holdings and does not reflect any recent share purchases or sales.
Cognyte Software Ltd. director Ron Shvili filed an initial ownership report showing beneficial ownership of 75,853 Ordinary Shares. This includes time-based restricted share units that convert into shares if vesting conditions are met.
The holdings include 7,263 Ordinary Shares represented by RSUs granted on May 1, 2024, with 3,632 vesting on May 1, 2026 and 3,631 vesting on May 1, 2027. They also include 19,048 Ordinary Shares represented by RSUs granted on March 24, 2025 that vest on March 24, 2026, and 20,974 Ordinary Shares represented by RSUs granted on March 16, 2026 that vest in four equal quarterly installments over the following year.